In this respect, an intriguing perspective is the therapeutic potential of inhibiting the PERK/p-eIF2α pathway to enhance protein synthesis and promote brain remodeling, thus improving long-term functional recovery after stroke. Here, EIF2AK3 is linked to stroke disorder.